Not applicableUnknownNCT02861872What this trial is testingIntra-peritoneal Chemotherapy in Ovarian CancerWho this might be right forOvarian NeoplasmsImmune ToleranceNeoplasms+1 more Radboud University Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT02567253What this trial is testingIntraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian CancerWho this might be right forOvarian CancerPrimary Peritoneal Cancer University Hospital, Ghent 56
Early research (Phase 1)Study completedNCT00006041What this trial is testingVaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00698451What this trial is testingCarboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal CancersWho this might be right forOvarian NeoplasmsFallopian Tube NeoplasmsPeritoneal Neoplasms Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 54
Large-scale testing (Phase 3)UnknownNCT04370925What this trial is testingEfficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal CarcinomatosisWho this might be right forColorectal Cancer Affiliated Cancer Hospital & Institute of Guangzhou Medical University 688
Not applicableUnknownNCT05400681What this trial is testingLiquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic CancerWho this might be right forPancreatic CancerPancreatic Adenocarcinoma Sonke Detlefsen 200
Early research (Phase 1)Study completedNCT00892736What this trial is testingVeliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous TherapyWho this might be right forBasal-Like Breast CarcinomaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+14 more National Cancer Institute (NCI) 98
Large-scale testing (Phase 3)Ended earlyNCT04729387What this trial is testingAlpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation DetectedWho this might be right forOvarian Cancer Novartis Pharmaceuticals 358
Not applicableLooking for participantsNCT02012699What this trial is testingIntegrated Cancer Repository for Cancer ResearchWho this might be right forPancreatic CancerThyroid CancerLung Cancer+47 more University of Nebraska 999,999
Not applicableUnknownNCT01539785What this trial is testingHyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer RecurrenceWho this might be right forFirst Recurrence of Ovarian Cancer Catholic University of the Sacred Heart 158
Not applicableWithdrawnNCT04368130What this trial is testingSIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer CareWho this might be right forOvarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+3 more Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00004081What this trial is testingDocetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal CancerWho this might be right forOvarian CancerPeritoneal Cavity Cancer Beth Israel Deaconess Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00872989What this trial is testingS0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer SWOG Cancer Research Network 129
Testing effectiveness (Phase 2)Active Not RecruitingNCT01116648What this trial is testingCediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast CancerWho this might be right forFallopian Tube CarcinomaOvarian Endometrioid AdenocarcinomaOvarian High Grade Serous Adenocarcinoma+4 more National Cancer Institute (NCI) 155
Testing effectiveness (Phase 2)Study completedNCT06087289What this trial is testingEvaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forEpithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer Novakand Pharma AB 18
Early research (Phase 1)Temporarily pausedNCT04711161What this trial is testingFirst-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.Who this might be right forOvarian Tumors Green3Bio, Inc. 73
Large-scale testing (Phase 3)Study completedNCT00052962What this trial is testingDebulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal CarcinomatosisWho this might be right forGastrointestinal Neoplasm National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT05407584What this trial is testingOregovomab and PLD in PARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum RetreatmentWho this might be right forPARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment Yonsei University 56
Early research (Phase 1)Study completedNCT00287885What this trial is testingDocetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerWho this might be right forCervical CancerEndometrial CancerFallopian Tube Cancer+5 more Masonic Cancer Center, University of Minnesota 18
Early research (Phase 1)UnknownNCT03283943What this trial is testingPDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.Who this might be right forOvarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer British Columbia Cancer Agency 22